Association between serum PCSK9 and coronary heart disease in patients with type 2 diabetes mellitus

被引：0
|
作者：
Juan Huang
Jun-Xu Gu
Kun Wang
Ai-Min Zhang
Ting-Ting Hong
Shan-Shan Li
Xiao-Qin Yao
Ming Yang
Yue Yin
Na Zhang
Ming Su
Jia-Jia Hu
Xue-Zhi Zhang
Mei Jia
机构：
[1] Peking University International Hospital,Department of traditional Chinese medicine
[2] Peking University People’s Hospital,Department of Clinical Laboratory
[3] Central South University,Department of Clinical Laboratory, Xiangya Hospital
[4] Peking University International Hospital,Department of Clinical Laboratory
来源：
Diabetology & Metabolic Syndrome | / 15卷
关键词：
PCSK9; T2DM; Coronary heart disease; Cardiovascular events;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] FATTY LIVER INDEX IS POSITIVELY ASSOCIATED WITH PCSK9 SERUM CONCENTRATIONS IN PATIENTS WITH TYPE 2 DIABETES
    Walus-Miarka, M.
    Kapusta, M.
    Idzior-Walus, B.
    Kawalec, E.
    ATHEROSCLEROSIS, 2020, 315 : E180 - E180
  • [22] Estimated Percentage of Patients With Stable Coronary Heart Disease Candidates for PCSK9 Inhibitors
    Cordero, Alberto
    Facila, Lorenzo
    Galve, Enrique
    Gonzalez Juanatey, Jose Ramon
    REVISTA ESPANOLA DE CARDIOLOGIA, 2019, 72 (06): : 518 - 519
  • [23] Association between glucometabolic control and degree of hypercoagulability in patients with combined type 2 diabetes mellitus and coronary heart disease
    Bratset, V
    Byrkjeland, R.
    Solheim, S.
    Arnesen, H.
    Seljeflot, I
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 292 - 292
  • [24] Smoking and coronary heart disease in patients with type 2 diabetes mellitus
    Kawada, Tomoyuki
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2017, 133 : 211 - 211
  • [25] Circulating PCSK9 in Statin-Treated Patients with Type 2 Diabetes Mellitus (T2DM)
    Walus-Miarka, Malgorzata
    Kapusta, Maria
    Kawalec, Ewa
    Idzior-Walus, Barbara
    DIABETES, 2018, 67
  • [26] Lack of association between plasma PCSK9 and LDL-cholesterol in patients with controlled type 1 diabetes
    Laugier-Robiolle, S.
    Verges, B.
    Hadjadj, S.
    Cariou, B.
    DIABETOLOGIA, 2015, 58 : S129 - S129
  • [27] Lack of association between plasma PCSK9 and LDL-apoB100 catabolism in patients with uncontrolled type 2 diabetes
    Verges, Bruno
    Duvillard, Laurence
    Brindisi, Marie Claude
    Gautier, Emmanuel
    Krempf, Michel
    Costet, Philippe
    Cariou, Bertrand
    ATHEROSCLEROSIS, 2011, 219 (01) : 342 - 348
  • [28] Association of genetic polymorphisms of PCSK9 with type 2 diabetes in Uygur Chinese population
    Meng-Meng Wang
    Chen-Fei Lu
    Shi-qi Yan
    Bao-Zhu Wang
    Gulinazi Yesitayi
    Yong-Liang Tian
    Yi-Tong Xiang-Ma
    BMC Cardiovascular Disorders, 22
  • [29] Circulating PCSK9 in patients with type 2 diabetes and related metabolic disorders
    Ibarretxe, Daiana
    Girona, Josefa
    Plana, Nuria
    Cabre, Anna
    Ferre, Raimon
    Amigo, Nuria
    Guaita, Sandra
    Mallol, Roger
    Heras, Mercedes
    Masana, Luis
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2016, 28 (02): : 71 - 78
  • [30] Association of genetic polymorphisms of PCSK9 with type 2 diabetes in Uygur Chinese population
    Wang, Meng-Meng
    Lu, Chen-Fei
    Yan, Shi-Qi
    Wang, Bao-Zhu
    Yesitayi, Gulinazi
    Tian, Yong-Liang
    Xiang-Ma
    Ma, Yi-Tong
    BMC CARDIOVASCULAR DISORDERS, 2022, 22 (01)
12345